Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 259

1.

Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing.

Karaboyas A, Zee J, Morgenstern H, Nolen JG, Hakim R, Kalantar-Zadeh K, Zager P, Pisoni RL, Port FK, Robinson BM.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1814-21. doi: 10.2215/CJN.02600315. Epub 2015 Aug 18.

2.

Anemia management trends in hospital-based dialysis centers (HBDCs), 2010 to 2013.

Coritsidis GN, Maglinte GA, Acharya A, Saxena A, Chang CL, Hill J, Gitlin M, Lafayette RA.

Clin Ther. 2014 Mar 1;36(3):408-18. doi: 10.1016/j.clinthera.2014.01.015. Epub 2014 Feb 28.

PMID:
24582713
3.

It's time to compare anemia management strategies in hemodialysis.

Coyne DW.

Clin J Am Soc Nephrol. 2010 Apr;5(4):740-2. doi: 10.2215/CJN.02490409. Epub 2010 Mar 18.

4.

Anemia Management among Hemodialysis Patients with High Ferritin Levels.

Einbinder Y, Agur T, Davidov K, Zitman-Gal T, Golan E, Benchetrit S.

Isr Med Assoc J. 2018 Jul;20(7):405-411.

5.

Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Robinson BM, Larkina M, Bieber B, Kleophas W, Li Y, Locatelli F, McCullough KP, Nolen JG, Port FK, Pisoni RL.

BMC Nephrol. 2017 Nov 9;18(1):330. doi: 10.1186/s12882-017-0745-9.

6.
7.

Economic considerations in a changing anemia environment.

Pizzi LT.

Am J Kidney Dis. 2008 Dec;52(6 Suppl):S29-33. doi: 10.1053/j.ajkd.2008.09.001.

PMID:
19010259
8.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
9.

Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related Quality of Life in Patients Receiving Hemodialysis.

Freburger JK, Ellis AR, Wang L, Butler AM, Kshirsagar AV, Winkelmayer WC, Brookhart MA.

Am J Kidney Dis. 2016 Feb;67(2):271-82. doi: 10.1053/j.ajkd.2015.09.011. Epub 2015 Oct 23.

PMID:
26508682
10.

Challenge of effectively using erythropoiesis-stimulating agents and intravenous iron.

Kapoian T.

Am J Kidney Dis. 2008 Dec;52(6 Suppl):S21-8. doi: 10.1053/j.ajkd.2008.09.004.

PMID:
19010258
11.
12.

Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients.

Kuragano T, Matsumura O, Matsuda A, Hara T, Kiyomoto H, Murata T, Kitamura K, Fujimoto S, Hase H, Joki N, Fukatsu A, Inoue T, Itakura I, Nakanishi T.

Kidney Int. 2014 Oct;86(4):845-54. doi: 10.1038/ki.2014.114. Epub 2014 Apr 23.

13.

Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?

Turenne MN, Cope EL, Porenta S, Mukhopadhyay P, Fuller DS, Pearson JM, Dahlerus C, Lantz B, Tentori F, Robinson BM.

J Am Soc Nephrol. 2015 Mar;26(3):754-64. doi: 10.1681/ASN.2013111232. Epub 2014 Oct 9.

14.

Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13.

Birnie K, Caskey F, Ben-Shlomo Y, Sterne JA, Gilg J, Nitsch D, Tomson C.

Nephrol Dial Transplant. 2017 Apr 1;32(4):692-698. doi: 10.1093/ndt/gfw043.

15.

Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.

Frankenfield D, Johnson CA, Wish JB, Rocco MV, Madore F, Owen WF.

Kidney Int. 2000 Feb;57(2):578-89.

16.
17.

Changing patterns of anemia management in US hemodialysis patients.

Freburger JK, Ng LJ, Bradbury BD, Kshirsagar AV, Brookhart MA.

Am J Med. 2012 Sep;125(9):906-14.e9. doi: 10.1016/j.amjmed.2012.03.011.

PMID:
22938926
18.
19.

Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort.

Kim T, Rhee CM, Streja E, Obi Y, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K.

Nephrol Dial Transplant. 2017 Feb 1;32(2):370-377. doi: 10.1093/ndt/gfw012.

20.

A comprehensive vision for intravenous iron therapy.

Coyne DW.

Am J Kidney Dis. 2008 Dec;52(6 Suppl):S14-20. doi: 10.1053/j.ajkd.2008.09.003.

PMID:
19010257

Supplemental Content

Support Center